e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Cystic lung diseases: lung granulomatosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessing sarcoidosis: The King‘s Sarcoidosis Questionnaire and the minimal important difference
A.S. Patel, A. Spinou, G. Keir, R.J. Siegert, T.M. Maher, E.A. Renzoni, A.U. Wells, I.J. Higginson, S.S. Birring (London, United Kingdom)
Source:
Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Session:
Cystic lung diseases: lung granulomatosis
Session type:
Thematic Poster Session
Number:
699
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A.S. Patel, A. Spinou, G. Keir, R.J. Siegert, T.M. Maher, E.A. Renzoni, A.U. Wells, I.J. Higginson, S.S. Birring (London, United Kingdom). Assessing sarcoidosis: The King‘s Sarcoidosis Questionnaire and the minimal important difference. Eur Respir J 2012; 40: Suppl. 56, 699
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
Source: Eur Respir J, 57 (6) 2100300; 10.1183/13993003.00300-2021
Year: 2021
The Severe Asthma Questionnaire (SAQ) - minimal clinically important difference and sensitivity to change
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021
King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference
Source: Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
Year: 2019
Impact of gender on disease activity, pulmonary function and health status in sarcoidosis patients – King’s sarcoidosis questionnaire (KSQ)
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Measuring properties of different dyspnea instruments in sarcoidosis
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Sarcoidosis: Changed phenotype and worsening of the course by overtime
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Correlation of King’s Sarcoidosis Questionnaire with clinical parameters
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Childhood pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Cognitive failure in sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Assessing the Liverpool Respiratory Symptom Questionnaire in children with cystic fibrosis
Source: Eur Respir J 2012; 39: 899-905
Year: 2012
A comparison of two scoring methods for the King’s sarcoidosis questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Health Related Quality of Life (HRQL) in sarcoidosis – Sarcoidosis Health Questionnaire (SHQ) and correlation with clinical course of sarcoidosis – follow up study
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006
EBUS vs EUS-B for diagnosing sarcoidosis:the International Sarcoidosis Assessment (ISA) RCT
Source: International Congress 2018 – EUS-B and EBUS: optimal utilisation of the EBUS scope
Year: 2018
What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease?
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire.
Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure
Year: 2018
Assessment of Burden of COPD tool: evidence not perception
Source: Eur Respir J, 50 (1) 1700756; 10.1183/13993003.00756-2017
Year: 2017
Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care
Year: 2020
Granulomatous lymphadenitis: Experience of a portuguese oncologic institute
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire in severe COPD
Source: Eur Respir J, 56 (6) 2001334; 10.1183/13993003.01334-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept